SARS-CoV-2 Mpro-IN-35

SARS-CoV-2 Mpro-IN-35 (compound 14) is a SARS-CoV-2 Mpro inhibitor. SARS-CoV-2 Mpro-IN-35 can be used for the research of SARS-CoV-2 virus[1].

Product Specifications

UNSPSC

12352005

Target

SARS-CoV

Related Pathways

Anti-infection

Field of Research

Infection

Smiles

ClC1=CN=C(C2(C)CCN(CC(N3C[C@@](C4)(C5=CC=C(Cl)C(Cl)=C5)[C@@]4([H])C3)=O)CC2)S1

Molecular Formula

C22H24Cl3N3OS

Molecular Weight

484.87

References & Citations

[1]Wilders H, et al. Expedited SARS-CoV-2 Main Protease Inhibitor Discovery through Modular 'Direct-to-Biology' Screening. Angew Chem Int Ed Engl. 2024 Dec 4:e202418314.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

STJ99654 200 µl

Anti-PI 3-kinase p8 alpha antibody

Ask

View Details

GTR15125739 1 Vial

Lentiviral mouse Tert shRNA (UAS) - Lentiviral mouse Tert shRNA (UAS, iRFP) (100)

Ask

View Details

E53A04730 50 µg

Recombinant Human CD46/MCP Protein (C-6His)

Ask

View Details

MF-0091473 100 µL

Anti-TrkA Antibody (8Z822)

Ask

View Details

RDC3068 10 µg

Mouse TROP-2 (NP_064431.2) VersaClone cDNA

Ask

View Details